Karius Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 59
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $165M
Latest Deal Amount
  • Investors
  • 15

Karius General Information

Description

Operator of a clinical laboratory testing centre created to focus on generating genomic insights for infectious diseases. The company's tests map each patient's microbial landscape from a single blood draw and develops molecular biology and data analysis tool that uses deep sequencing to detect minuscule traces of microbial DNA directly from blood, enabling physicians to make rapid life-saving treatment decisions.

Contact Information

Website
www.kariusdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 975 Island Drive
  • Suite 101
  • Redwood City, CA 94065
  • United States
+1 (866) 000-0000

Karius Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Karius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 14-Feb-2020 $165M 00000 Completed Startup
4. Debt - General 30-Nov-2018 0000 000.00 Completed Startup
3. Early Stage VC (Series A) 07-Aug-2017 0000 000.00 Completed Startup
2. Accelerator/Incubator $5.27M Completed Startup
1. Seed Round 20-Oct-2014 $5.27M $5.27M 0000 Completed Startup
To view Karius’s complete valuation and funding history, request access »

Karius Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Karius’s complete cap table history, request access »

Karius Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical laboratory testing centre created to focus on generating genomic insights for infectious diseases
Biotechnology
Redwood City, CA
59 As of 2020
00000
00000000000 00000

0000000

t nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt
0000000000000
Salt Lake City, UT
00 As of 0000
0000
000000 - 000 0000

00000000

a commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu
0000000 0000000 0000000
San Diego, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Karius Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IDbyDNA Venture Capital-Backed Salt Lake City, UT 00 0000 000000 - 000 0000
00000000 000000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
000000 0000000000 Venture Capital-Backed Saint Louis, MO 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
00000 Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
You’re viewing 5 of 10 competitors. Get the full list »

Karius Executive Team (7)

Name Title Board Seat Contact Info
Alec Ford Chief Executive Officer
Sivan Bercovici Ph.D Chief Technology Officer
Tim Blauwkamp Ph.D Co-Founder, Chief Scientific Officer & Board Member
Karen To Director of Finance
Mickey Kertesz Ph.D Co-Founder, Chief Product Officer, President & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Karius Board Members (5)

Name Representing Role Since
Mickey Kertesz Ph.D Karius Co-Founder, Chief Product Officer, President & Board Member 000 0000
Tim Blauwkamp Ph.D Karius Co-Founder, Chief Scientific Officer & Board Member 000 0000
To view Karius’s complete board members history, request access »

Karius Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Karius Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
General Catalyst Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0
SoftBank Investment Advisers PE/Buyout Minority 000 0000 000000 0
aMoon Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial